SXI Life Sciences
7.288,53
PKT
+69,99
PKT
+0,97
%
Werbung
Analysen zu SXI Life Sciences-Werten
Datum | Rating | Analyst | |
---|---|---|---|
11.09.14 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
09.09.14 | Novartis overweight | JP Morgan Chase & Co. | |
04.09.14 | Novartis Outperform | BNP PARIBAS | |
04.09.14 | Roche buy | UBS AG | |
03.09.14 | Novartis Halten | Independent Research GmbH | |
02.09.14 | BB Biotech Halten | Independent Research GmbH | |
02.09.14 | Novartis overweight | JP Morgan Chase & Co. | |
01.09.14 | Novartis buy | UBS AG | |
01.09.14 | Novartis Hold | Kepler Cheuvreux | |
01.09.14 | Novartis Hold | Deutsche Bank AG | |
26.08.14 | Novartis Hold | Kelper Cheuvreux | |
26.08.14 | Roche Hold | S&P Capital IQ | |
26.08.14 | Roche Outperform | Credit Suisse Group | |
26.08.14 | Roche buy | UBS AG | |
25.08.14 | Roche buy | Société Générale Group S.A. (SG) | |
22.08.14 | Roche buy | UBS AG | |
22.08.14 | Novartis Outperform | Credit Suisse Group | |
21.08.14 | Novartis buy | Société Générale Group S.A. (SG) | |
21.08.14 | Roche buy | Deutsche Bank AG | |
21.08.14 | Novartis Hold | Deutsche Bank AG | |
19.08.14 | Novartis buy | UBS AG | |
19.08.14 | Roche overweight | JP Morgan Chase & Co. | |
18.08.14 | Roche buy | UBS AG | |
05.08.14 | Roche buy | UBS AG | |
05.08.14 | Novartis Hold | Deutsche Bank AG | |
29.07.14 | Roche buy | Citigroup Corp. | |
29.07.14 | Roche buy | Société Générale Group S.A. (SG) | |
25.07.14 | Roche overweight | JP Morgan Chase & Co. | |
25.07.14 | Roche overweight | Morgan Stanley | |
25.07.14 | Roche Outperform | Bernstein Research | |
25.07.14 | Roche buy | Société Générale Group S.A. (SG) | |
25.07.14 | Roche overweight | Barclays Capital | |
21.07.14 | Novartis Underweight | Morgan Stanley | |
21.07.14 | BB Biotech buy | Close Brothers Seydler Research AG | |
21.07.14 | Novartis Equal weight | Barclays Capital | |
21.07.14 | Novartis overweight | JP Morgan Chase & Co. | |
18.07.14 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
18.07.14 | BB Biotech buy | equinet AG | |
17.07.14 | Roche buy | UBS AG | |
17.07.14 | Roche overweight | Morgan Stanley |